Literature DB >> 7562756

Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.

M Abu-Shakra1, M B Urowitz, D D Gladman, J Gough.   

Abstract

OBJECTIVE: To analyze the factors associated with mortality in patients with systemic lupus erythematosus (SLE), followed prospectively in a single center.
METHODS: The study included 665 patients with SLE followed over a 20-year period according to a standard protocol. Clinical laboratory information has been entered into a database. Univariate analysis was carried out to identify prognostic factors of death. The Cox proportional hazard regression model was used to estimate risk ratio of death.
RESULTS: Renal damage, thrombocytopenia, lung involvement, systemic lupus erythematosus disease activity index (SLEDAI) > or = 20 at presentation, and age > or = 50 at diagnosis were predictive factors for mortality in the univariate as well as in the multivariate analyses. Hypertension and ischemic heart disease were significantly associated with death only in the univariate analysis.
CONCLUSION: Renal damage, thrombocytopenia, SLEDAI > or = 20 at presentation, lung involvement, and age > or = 50 at diagnosis are prognostic factors associated with mortality.

Entities:  

Mesh:

Year:  1995        PMID: 7562756

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  38 in total

1.  IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.

Authors:  Joy Jones Buie; Ludivine L Renaud; Robin Muise-Helmericks; Jim C Oates
Journal:  J Immunol       Date:  2017-08-04       Impact factor: 5.422

2.  Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre.

Authors:  D L Huong; B Wechsler; D Vauthier-Brouzes; H Beaufils; G Lefebvre; J C Piette
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 3.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

4.  Intraabdominal cryptococcal lymphadenitis in a patient with systemic lupus erythematosus.

Authors:  Sang-Hyon Kim; Sung-Dong Kim; Hae-Rim Kim; Chong-Hyeon Yoon; Sang-Heon Lee; Ho-Youn Kim; Sung-Hwan Park
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

5.  Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality.

Authors:  Anna Broder; Saakshi Khattri; Ruchika Patel; Chaim Putterman
Journal:  J Rheumatol       Date:  2011-09-01       Impact factor: 4.666

6.  Case report-right iliac fossa mass in an HIV-positive woman. Cryptococcal meningitis.

Authors:  J J Kumwenda; M Nyirenda; T Tomoka; D Ricken; K Chalulu; S Kamiza
Journal:  Malawi Med J       Date:  2010-06       Impact factor: 0.875

Review 7.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

Review 8.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Patient-Reported Outcomes Predict Mortality in Lupus.

Authors:  Desiree R Azizoddin; Meenakshi Jolly; Shilpa Arora; Ed Yelin; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-13       Impact factor: 4.794

10.  New and emerging treatment approaches to lupus.

Authors:  Marion Haubitz
Journal:  Biologics       Date:  2010-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.